NO168176C - Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider

Info

Publication number: NO168176C
Authority: NO; Norway
Prior art keywords: preparation; therapeutic active; substituted benzamides; analogue procedure; analogue
Prior art date: 1985-12-19

Application number

NO865148A

Other languages

English (en)

Other versions

NO865148D0 (no

NO865148L (no

NO168176B (no

Inventor

Jacques Acher

Jean-Claude Monier

Jean-Paul Schmitt

Renee Gardaix-Luthereau

Brenda Costall

Robert Naylor

Original Assignee

Delagrange Laboratoires

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-12-19

Filing date

1986-12-18

Publication date

1992-01-22

1986-12-18 Application filed by Delagrange Laboratoires filed Critical Delagrange Laboratoires

1986-12-18 Publication of NO865148D0 publication Critical patent/NO865148D0/no

1987-06-22 Publication of NO865148L publication Critical patent/NO865148L/no

1991-03-01 Priority to NO910822A priority Critical patent/NO910822D0/no

1991-10-14 Publication of NO168176B publication Critical patent/NO168176B/no

1992-01-22 Publication of NO168176C publication Critical patent/NO168176C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Otolaryngology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

NO865148A 1985-12-19 1986-12-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider NO168176C (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO910822A NO910822D0 (no)	1985-12-19	1991-03-01	Alkylbenzoater.

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8518829A FR2592042B1 (fr)	1985-12-19	1985-12-19	Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques

Publications (4)

Publication Number	Publication Date
NO865148D0 NO865148D0 (no)	1986-12-18
NO865148L NO865148L (no)	1987-06-22
NO168176B NO168176B (no)	1991-10-14
NO168176C true NO168176C (no)	1992-01-22

Family

ID=9325965

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO865148A NO168176C (no)	1985-12-19	1986-12-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider

Country Status (37)

Country	Link
US (2)	US4835172A (no)
EP (1)	EP0236646B1 (no)
JP (1)	JPS62246553A (no)
KR (1)	KR930004653B1 (no)
CN (1)	CN1018454B (no)
AR (1)	AR242193A1 (no)
AT (1)	ATE57376T1 (no)
AU (1)	AU586057B2 (no)
CA (2)	CA1298301C (no)
CH (1)	CH671396A5 (no)
CS (1)	CS274285B2 (no)
DD (1)	DD260495A5 (no)
DE (2)	DE3674916D1 (no)
DK (1)	DK612886A (no)
ES (1)	ES2036178T3 (no)
FI (1)	FI865190A (no)
FR (1)	FR2592042B1 (no)
GB (1)	GB2184723B (no)
GR (1)	GR3002524T3 (no)
HU (1)	HU196794B (no)
IE (1)	IE59212B1 (no)
IL (1)	IL81010A (no)
IN (1)	IN163130B (no)
IS (1)	IS1448B6 (no)
MA (1)	MA20835A1 (no)
NO (1)	NO168176C (no)
NZ (1)	NZ218675A (no)
OA (1)	OA08564A (no)
PH (2)	PH24365A (no)
PL (1)	PL148408B1 (no)
PT (1)	PT83982B (no)
SU (1)	SU1496632A3 (no)
TN (1)	TNSN86165A1 (no)
YU (1)	YU44796B (no)
ZA (1)	ZA869560B (no)
ZM (1)	ZM10686A1 (no)
ZW (1)	ZW24886A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0295350B1 (fr) *	1987-06-17	1992-11-11	Laboratoires DELAGRANGE	Application du N-[2-(diethylamino)ethyl]2-methoxy 4-[(1-H 4,5-dihydro-2-imidazolyl) amino]5-chloro benzamide comme anxiolytique et anti-psychotique
FR2640139A1 (fr) *	1988-12-14	1990-06-15	Delagrange Laboratoires	Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) *	1988-12-20	1990-06-22	Delagrange Laboratoires	Application de benzamides substitues comme anxiolytiques et anti-psychotiques
FR2645742A1 (fr) *	1989-04-12	1990-10-19	Delagrange Laboratoires	Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
US5401851A (en) *	1992-06-03	1995-03-28	Eli Lilly And Company	Angiotensin II antagonists
US20050140688A1 (en) *	2003-12-29	2005-06-30	Kim Pallister	Method and mechanism for programmable filtering of texture map data in 3D graphics subsystems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3342826A (en) *	1964-01-13	1967-09-19	Ile De France	Heterocyclic aminoalkyl benzamides
FR1539104A (fr) *	1967-07-31	1968-09-13	Ile De France	Nouveaux benzamides et leur procédé de préparation
US3682968A (en) *	1969-06-25	1972-08-08	Merck & Co Inc	Anti-inflammatory salicylic acid derivatives
DE1963193A1 (de) *	1969-12-17	1971-06-24	Bayer Ag	N-substituierte 2-Arylimino-oxazolidine,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasiticide
FR2432513A1 (fr) *	1977-10-24	1980-02-29	Merieux Inst	Nouveaux derives de la thiazoline et leur application comme medicaments
DE2905883A1 (de) *	1979-02-16	1980-08-28	Boehringer Sohn Ingelheim	Radioimmuntest fuer clonidin
CA1201066A (en) *	1981-11-20	1986-02-25	Alcon Laboratories, Inc.	N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl\|-acetamide solutions for lowering intraocular pressure
US4461904A (en) *	1981-11-20	1984-07-24	Alcon Laboratories, Inc.	2-(Trisubstituted phenylimino)-imidazolines
DE3514351A1 (de) *	1985-04-20	1986-11-06	Boehringer Ingelheim KG, 6507 Ingelheim	Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS6341471A (ja) *	1986-08-08	1988-02-22	Nippon Soda Co Ltd	オキサ（チア）ゾリジン誘導体、その製造法及び殺ダニ剤
US4826990A (en) *	1987-09-30	1989-05-02	American Home Products Corporation	2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents

1985
- 1985-12-19 FR FR8518829A patent/FR2592042B1/fr not_active Expired
1986
- 1986-12-15 IE IE327086A patent/IE59212B1/en not_active IP Right Cessation
- 1986-12-15 EP EP86402796A patent/EP0236646B1/fr not_active Expired - Lifetime
- 1986-12-15 ES ES198686402796T patent/ES2036178T3/es not_active Expired - Lifetime
- 1986-12-15 AT AT86402796T patent/ATE57376T1/de active
- 1986-12-15 DE DE8686402796T patent/DE3674916D1/de not_active Expired - Lifetime
- 1986-12-16 IN IN983/MAS/86A patent/IN163130B/en unknown
- 1986-12-16 CH CH4997/86A patent/CH671396A5/fr not_active IP Right Cessation
- 1986-12-17 IS IS3178A patent/IS1448B6/is unknown
- 1986-12-17 GB GB8630143A patent/GB2184723B/en not_active Expired
- 1986-12-17 PH PH34606A patent/PH24365A/en unknown
- 1986-12-17 DE DE19863643103 patent/DE3643103A1/de not_active Withdrawn
- 1986-12-17 IL IL81010A patent/IL81010A/xx not_active IP Right Cessation
- 1986-12-17 HU HU865271A patent/HU196794B/hu not_active IP Right Cessation
- 1986-12-17 DD DD86297795A patent/DD260495A5/de not_active IP Right Cessation
- 1986-12-17 AR AR86306202A patent/AR242193A1/es active
- 1986-12-17 MA MA21067A patent/MA20835A1/fr unknown
- 1986-12-17 NZ NZ218675A patent/NZ218675A/xx unknown
- 1986-12-18 FI FI865190A patent/FI865190A/fi not_active Application Discontinuation
- 1986-12-18 NO NO865148A patent/NO168176C/no unknown
- 1986-12-18 PL PL1986263078A patent/PL148408B1/pl unknown
- 1986-12-18 CN CN86108972A patent/CN1018454B/zh not_active Expired
- 1986-12-18 ZM ZM106/86A patent/ZM10686A1/xx unknown
- 1986-12-18 SU SU864028722A patent/SU1496632A3/ru active
- 1986-12-18 OA OA59022A patent/OA08564A/xx unknown
- 1986-12-18 KR KR1019860010868A patent/KR930004653B1/ko not_active IP Right Cessation
- 1986-12-18 DK DK612886A patent/DK612886A/da not_active Application Discontinuation
- 1986-12-18 CA CA000525719A patent/CA1298301C/fr not_active Expired - Lifetime
- 1986-12-18 AU AU66687/86A patent/AU586057B2/en not_active Ceased
- 1986-12-18 YU YU2179/86A patent/YU44796B/xx unknown
- 1986-12-19 PT PT83982A patent/PT83982B/pt not_active IP Right Cessation
- 1986-12-19 ZA ZA869560A patent/ZA869560B/xx unknown
- 1986-12-19 JP JP61305136A patent/JPS62246553A/ja active Pending
- 1986-12-19 CS CS960386A patent/CS274285B2/cs unknown
- 1986-12-19 TN TNTNSN86165A patent/TNSN86165A1/fr unknown
- 1986-12-19 US US06/943,708 patent/US4835172A/en not_active Expired - Fee Related
- 1986-12-19 ZW ZW248/86A patent/ZW24886A1/xx unknown
1988
- 1988-02-17 PH PH36522A patent/PH24469A/en unknown
1989
- 1989-03-13 US US07/322,122 patent/US4914117A/en not_active Expired - Fee Related
1990
- 1990-10-22 CA CA000615908A patent/CA1299579C/fr not_active Expired - Lifetime
- 1990-11-13 GR GR90400910T patent/GR3002524T3/el unknown

Also Published As

Publication number	Publication date
FR2592042B1 (fr)	1988-03-25
GR3002524T3 (en)	1993-01-25
YU44796B (en)	1991-02-28
DK612886A (da)	1987-06-20
NO865148D0 (no)	1986-12-18
CN1018454B (zh)	1992-09-30
HUT43844A (en)	1987-12-28
KR870006008A (ko)	1987-07-08
IL81010A (en)	1991-06-30
IS3178A7 (is)	1987-06-20
IE863270L (en)	1987-06-19
DE3643103A1 (de)	1987-06-25
IE59212B1 (en)	1994-01-26
FI865190A (fi)	1987-06-20
GB2184723A (en)	1987-07-01
YU217986A (en)	1987-12-31
OA08564A (fr)	1988-09-30
ZA869560B (en)	1987-11-25
ZM10686A1 (en)	1987-11-27
US4914117A (en)	1990-04-03
EP0236646A1 (fr)	1987-09-16
IN163130B (no)	1988-08-13
PH24469A (en)	1990-07-18
PT83982B (pt)	1989-01-17
PT83982A (en)	1987-01-01
PH24365A (en)	1990-06-13
AU6668786A (en)	1987-06-25
MA20835A1 (fr)	1987-07-01
KR930004653B1 (ko)	1993-06-02
IS1448B6 (is)	1991-01-16
CS274285B2 (en)	1991-04-11
AR242193A1 (es)	1993-03-31
CS960386A2 (en)	1990-09-12
CA1299579C (fr)	1992-04-28
CA1298301C (fr)	1992-03-31
PL148408B1 (en)	1989-10-31
CN86108972A (zh)	1987-11-18
FR2592042A1 (fr)	1987-06-26
GB8630143D0 (en)	1987-01-28
EP0236646B1 (fr)	1990-10-10
DK612886D0 (da)	1986-12-18
ES2036178T3 (es)	1993-05-16
JPS62246553A (ja)	1987-10-27
TNSN86165A1 (fr)	1990-01-01
NZ218675A (en)	1990-06-26
NO865148L (no)	1987-06-22
ATE57376T1 (de)	1990-10-15
SU1496632A3 (ru)	1989-07-23
DD260495A5 (de)	1988-09-28
ZW24886A1 (en)	1987-05-13
GB2184723B (en)	1989-12-28
DE3674916D1 (de)	1990-11-15
HU196794B (en)	1989-01-30
NO168176B (no)	1991-10-14
FI865190A0 (fi)	1986-12-18
US4835172A (en)	1989-05-30
CH671396A5 (no)	1989-08-31
PL263078A1 (en)	1988-04-14
AU586057B2 (en)	1989-06-29
IL81010A0 (en)	1987-03-31

Publication	Publication Date	Title
NO864126D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO164025C (no)	1990-08-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO163857C (no)	1990-08-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO162189C (no)	1989-11-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO864879L (no)	1987-06-09	Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO161497C (no)	1989-08-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO874153D0 (no)	1987-10-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO864674D0 (no)	1986-11-21	Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO864130L (no)	1987-04-21	Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO164541C (no)	1990-10-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO165071C (no)	1990-12-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO165545C (no)	1991-02-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
NO164295C (no)	1990-09-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO863373D0 (no)	1986-08-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no)	1986-10-24	Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO164899C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873680D0 (no)	1987-09-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO873835L (no)	1988-03-16	Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO162188C (no)	1989-11-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO864101L (no)	1987-04-21	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO168176C (no)	1992-01-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
NO170012C (no)	1992-09-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
NO157618C (no)	1988-04-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamid-inderivater.